The closing price of Cardlytics Inc (NASDAQ: CDLX) was $8.18 for the day, up 15.21% from the previous closing price of $7.10. In other words, the price has increased by $+1.08 from its previous closing price. On the day, 880527 shares were traded. CDLX stock price reached its highest trading level at $8.28 during the session, while it also had its lowest trading level at $7.24.
Ratios:
Our analysis of CDLX’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 1.15 and its Current Ratio is at 1.15. In the meantime, Its Debt-to-Equity ratio is 1.16 whereas as Long-Term Debt/Eq ratio is at 1.02.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Lake Street on November 29, 2023, initiated with a Buy rating and assigned the stock a target price of $13.
On September 08, 2022, Wells Fargo Downgraded its rating to Underweight which previously was Equal Weight and also lowered its target price recommendation from $14 to $13.
Wells Fargo Downgraded its Overweight to Equal Weight on July 14, 2022, whereas the target price for the stock was revised from $72 to $15.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Jan 24 when Gupta Amit sold 72,658 shares for $6.10 per share. The transaction valued at 443,286 led to the insider holds 102,342 shares of the business.
SOSIN CLIFFORD sold 17,155 shares of CDLX for $120,128 on Jan 12. The 10% Owner now owns 5,361,961 shares after completing the transaction at $7.00 per share. On Jan 03, another insider, Temsamani Karim Saad, who serves as the Chief Executive Officer of the company, sold 31,123 shares for $7.77 each. As a result, the insider received 241,826 and left with 277,735 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CDLX now has a Market Capitalization of 321.49M and an Enterprise Value of 493.69M. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.06 while its Price-to-Book (P/B) ratio in mrq is 1.40. Its current Enterprise Value per Revenue stands at 1.63 whereas that against EBITDA is -1.32.
Stock Price History:
Over the past 52 weeks, CDLX has reached a high of $19.57, while it has fallen to a 52-week low of $2.57. The 50-Day Moving Average of the stock is 7.35, while the 200-Day Moving Average is calculated to be 9.63.
Shares Statistics:
CDLX traded an average of 734.88K shares per day over the past three months and 665.47k shares per day over the past ten days. A total of 39.25M shares are outstanding, with a floating share count of 36.32M. Insiders hold about 7.47% of the company’s shares, while institutions hold 74.40% stake in the company. Shares short for CDLX as of Jan 31, 2024 were 4.16M with a Short Ratio of 5.66, compared to 3.72M on Dec 29, 2023. Therefore, it implies a Short% of Shares Outstanding of 10.61% and a Short% of Float of 12.28%.
Earnings Estimates
The firm’s stock currently is rated by 3 analysts. On average, analysts expect EPS of $0.12 for the current quarter, with a high estimate of $0.25 and a low estimate of $0.03, while EPS last year was -$0.29. The consensus estimate for the next quarter is -$0.21, with high estimates of -$0.03 and low estimates of -$0.34.
Analysts are recommending an EPS of between -$0.21 and -$0.38 for the fiscal current year, implying an average EPS of -$0.29. EPS for the following year is -$0.07, with 3 analysts recommending between $0.68 and -$0.63.
Revenue Estimates
It is expected that $90B in revenue will be generated in the current quarter, according to 3 analysts. It ranges from a high estimate of $89.63M to a low estimate of $89.5M. As of the current estimate, Cardlytics Inc’s year-ago sales were $82.5M, an estimated increase of 8.50% from the year-ago figure. For the next quarter, 3 analysts are estimating revenue of $66.46M, an increase of 3.30% less than the figure of $8.50% in the same quarter last year. There is a high estimate of $68M for the next quarter, whereas the lowest estimate is $63.57M.
A total of 3 analysts have provided revenue estimates for CDLX’s current fiscal year. The highest revenue estimate was $309.66M, while the lowest revenue estimate was $304.26M, resulting in an average revenue estimate of $307.84M. In the same quarter a year ago, actual revenue was $298.54M, up 3.10% from the average estimate. Based on 3 analysts’ estimates, the company’s revenue will be $328.22M in the next fiscal year. The high estimate is $333.9M and the low estimate is $317.57M. The average revenue growth estimate for next year is up 6.60% from the average revenue estimate for this year.
